APA

Boccon-Gibod C., Talbot A., Le Bras F., Frenzel L., Royer B., Harel S., Lombion N., Belhadj K., Cuccuini W. & Arnulf B. (20210201). Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myeloma. : British journal of haematology.

Chicago

Boccon-Gibod Clémentine, Talbot Alexis, Le Bras Fabien, Frenzel Laurent, Royer Bruno, Harel Stephanie, Lombion Naelle, Belhadj Karim, Cuccuini Wendy and Arnulf Bertrand. 20210201. Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myeloma. : British journal of haematology.

Harvard

Boccon-Gibod C., Talbot A., Le Bras F., Frenzel L., Royer B., Harel S., Lombion N., Belhadj K., Cuccuini W. and Arnulf B. (20210201). Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myeloma. : British journal of haematology.

MLA

Boccon-Gibod Clémentine, Talbot Alexis, Le Bras Fabien, Frenzel Laurent, Royer Bruno, Harel Stephanie, Lombion Naelle, Belhadj Karim, Cuccuini Wendy and Arnulf Bertrand. Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myeloma. : British journal of haematology. 20210201.